Clinical Trial Update: ALCAR Prophylaxis Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on acetyl-L-carnitine used as prophylaxis for HIV infection-related distal symmetric polyneuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Symmetric Polyneuropathy
• HIV Infection

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)

Snippet

Sponsor: Royal Free Hampstead NHS Trust | Conditions: HIV Infections, Distal Symmetric Polyneuropathy | Phase 2 | Status: UNKNOWN